You might be right Jonzobot. Though I would argue for full results Q4'19 (i.e. AHA 2019) instead of Q1 2020. First cardio/diabetes/renal conference in 2020 is ACC in March 2020. I sure hope full results in less than a year!!!! Amarin's blueprint is looking like a good template for Resverlogix.....perhaps substitue 2019 for Amarin's 2018 REDUCE-IT milestones below. If BETonMACE is at 220+ as of mid-February, this is pretty close to the 90% mark.

January 2018: Reached 90% mark for reported and documented events

April 2018:Reached target event #

June 2018: Last patient study visit 

Sept 2018: Top-line results

Nov 2018: Full results presented and published